Novel A18T and pA29S substitutions in α-synuclein may be associated with sporadic Parkinson's disease

Larger population based studies are needed to determine the pathogenicity of the A18T and A29S substitutions. Our findings highlight the possible role of rare variants contributing to disease risk and may support further screening of the SNCA gene in sporadic PD patients from different populations.